Edoxaban 480449-70-5 is a direct factor X (FXa) inhibitor, and FXa is the main target in the development of a new generation of anticoagulant drugs, the characteristics of its oral administration to facilitate the clinical use of drugs; Clinical trials confirm the safety and efficacy of this product. Therefore, the goods will be have more advantages  in the field of anticoagulant drugs and thus get more business opportunities. With the aging of the population, the increasing incidence of cardiovascular disease, the demand for anticoagulant drugs continues to increase, FXa direct inhibitor is the development trend of anticoagulants, many have been approved in the international market, we believe that these drugs will be give patients more benefit.

Thera. Category: Anticoagulant drug

Cas No.: 480449-70-5

Synonym: Edoxaban N-(5-Chloro-2-pyridinyl)-N'-[(1S,2R,4S)-4-[(dimethylamino)carbonyl]-2-[[(4,5,6,7-tetrahydro-5-methylthiazolo[5,4-c]pyridin-2-yl)carbonyl]amino]cyclohexyl]ethanediamide;5- chloro -2- pyridine -N, N-dimethyl formamidine;edoxaban;N-(5-Chloro-2-pyridinyl)-N'-[(1S,2R,4S)-4-[(dimethylamino)carbonyl]-2-[[(4,5,6,7-tetrahydro-5-methylthiazolo[5,4-c]pyridin-2-yl)carbonyl]amino]cyclohexyl]ethanediamide;EthanediaMide, N1-(5-chlo...;EthanediaMide, N1-(5-chloro-2-pyridinyl)-N2-[(1S,2R,4S)-4-[(diMethylaMino)carbonyl]-2-[[(4,5,6,7-tetrahydro-5-Methylthiazolo[5,4-c]pyridin-2-yl)carbonyl]aMino]cyclohexyl]-;DU-176;Edoxaban(DU-176);

Molecular Formula: C24H30ClN7O4S

Molecular Weight: 548.065

Purity: ≥98.%

Packing:Export worthy packing

Material Safety Data Sheet:Available on request

Related product:

Edoxaban (tosylate Monohydrate) 1229194-11-9

Edoxaban 912273-65-5 

Edoxaban 480449-70-5

Tert-Butyl(1R,2S,5S)-2-azido-5-[(dimethylamino)carbonyl]cyclohexylcarbamate oxalic acid Cas 1353893-22-7